About IMCannabis
IMCannabis is a company based in Herzliya (Israel) founded in 2008. The company has 55 employees as of December 31, 2024. IMCannabis has completed 2 acquisitions, including Highland Grow and MYM Nutraceuticals. IMCannabis operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter Herzliya, Israel
- Employees 55 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Im Cannabis Corp.
-
Annual Revenue
$39.44 M (USD)9.07as on Dec 31, 2024
-
Net Profit
-$7.73 M (USD)-9.8as on Dec 31, 2024
-
EBITDA
-$3.52 M (USD)48.26as on Dec 31, 2024
-
Latest Funding Round
$1.54 M (USD), Post-IPO
Nov 12, 2024
-
Investors
-
Employee Count
55
as on Dec 31, 2024
-
Investments & Acquisitions
Highland Grow
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IMCannabis
IMCannabis is a publicly listed company on the NASDAQ with ticker symbol IMCC in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of IMCannabis
Unlock access to complete
Funding Insights of IMCannabis
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $1.5M
-
First Round
First Round
(17 Jun 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Post-IPO - IMCannabis | Valuation |
investors |
|
| Jan, 2023 | Amount | Post-IPO - IMCannabis | Valuation |
investors |
|
| Oct, 2022 | Amount | Post-IPO - IMCannabis | Valuation |
investors |
|
Investors in IMCannabis
IMCannabis has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Marc Lustig.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ML
Marc Lustig |
Angel investor and entrepreneur, focused on tech startups in India.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IMCannabis
IMCannabis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Highland Grow and MYM Nutraceuticals.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis products are manufactured by Highland Grow in Canada.
|
2018 | ||||
|
Design-build services for cannabis cultivation facilities are provided.
|
2014 |
Financial Statements - IMCannabis
Imcannabis Comparisons
Competitors of IMCannabis
IMCannabis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Medical cannabis products are provided based on GMP processes.
|
|
| domain | founded_year | HQ Location |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| domain | founded_year | HQ Location |
Manufacturer of medicinal cannabis for therapeutic use
|
Frequently Asked Questions about IMCannabis
IMCannabis was founded in 2008 and raised its 1st funding round 12 years after it was founded.
IMCannabis is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Oren Shuster is the current CEO of IMCannabis.
As of Dec 31, 2024, the latest employee count at IMCannabis is 55.
Annual revenue of IMCannabis is $39.44M as on Dec 31, 2024.
Developer of medical cannabis productss. It has developed strains oils, and products for various diseases like oncology, PTSD, epilepsy, Crohns colitis, ALS, fibromyalgia, multiple sclerosis, Parkinsons, Tourette, chronic pain, eating disorder, and others.
IMCannabis's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
Yes, IMCannabis is publicly traded on NASDAQ under the ticker symbol IMCC.
IMCannabis has made 2 acquisitions, including Highland Grow, and MYM Nutraceuticals.
IMCannabis has 1 investor. Key investors include Marc Lustig.
The ticker symbol of IMCannabis is IMCC on NASDAQ.